A dose of psilocybin helps smokers quit in new study
March 15, 2026
21,070
2,392
94
11.80%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Npr Episodes Around March 15, 2026
See what was published immediately before and after this episode.
1:00Now PlayingA dose of psilocybin helps smokers quit in new study
YouTube Description
as posted by the channelThe study enrolled just over 80 current smokers, who were randomly separated into two groups: one used a nicotine patch, the other ingested a relatively high dose of pure psilocybin just one time. At the 6-month mark, the psilocybin group had more than six times greater odds of being abstinent from cigarettes than their counterparts who had nicotine. Everyone in the trial also underwent 13 weeks of cognitive behavioral therapy.
Recent interest in psychedelics has mostly focused on depression and other mental health conditions. Psilocybin could be considered for drug approval in the next few years.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.